13
Dec 2022
14:30 E.S.T.

Cellectis Live Webcast Presentation- December 13, 2022

Download the PDF file
12
Dec 2022
23:00 E.S.T.

AMELI-01:Preliminary Results from A Phase I Trial of UCART123v1.2, an Anti-CD123 Allogeneic CAR-T Cell Product, in Adult Patients with Relapsed or Refractory (R/R) CD123+ Acute Myeloid Leukemia- ASH 2022- Oral Presentation

Download the PDF file
10
Dec 2022
23:30 E.S.T.

Preclinical Activity of Allogeneic CS1-Specific CAR T-Cells (UCARTCS1) in Multiple Myeloma – ASH 2022 – Poster Presentation

Download the PDF file
10
Nov 2022
14:00 E.S.T.

Multi-armored allogeneic MUC-1 CAR T-cells efficiently control triple negative breast cancer tumor growth- SITC 2022- Poster Presentation

Download the PDF file
10
Nov 2022
14:00 E.S.T.

TALEN®-edited smart CAR T-cells leverage solid tumor microenvironment for specific and effective immunotherapy – SITC 2022- Poster Presentation

Download the PDF file
26
Oct 2022
13:00 E.S.T.

TALEN®-edited SMART CAR T-cells leverage solid tumor microenvironment for specific and effective immunotherapy- ENA 2022- Poster Presentation

Download the PDF file
13
Oct 2022
13:00 E.S.T.

Non-viral DNA delivery associated to TALEN® gene editing leads to highly efficient correction of sickle cell mutation in long-term repopulating hematopoietic stem cells- ESGCT 2022- Oral Presentation

Download the PDF file
11
Oct 2022
20:27 E.S.T.

Non-viral DNA delivery associated to TALEN® gene editing leads to highly efficient correction of sickle cell mutation in long-term repopulating hematopoietic stem cells- ESGCT 2022- Abstract

Download the PDF file
11
Oct 2022
20:26 E.S.T.

TALEN®-mediated engineering of HSPC enables systemic delivery of IDUA – ESGCT 2022- Abstract

Download the PDF file
11
Oct 2022
18:33 E.S.T.

TALEN®-mediated engineering of HSPC enables systemic delivery of IDUA- ESGCT 2022- Poster Presentation

Download the PDF file